Analyst Recommendations

248.86 1.25(0.50%)07/03/2024
Alnylam Pharmaceuticals Inc (ALNY)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy15
Neutral9
Outperform9
Equal-Weight4
Market Perform1
Overweight1

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades